Articles about Product Safety

Recent Quotes

My Watchlist

Top Indices

My Portfolio

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Raises Approximately $5.6 Million in PIPE Financing

Today 10:38 EDT

Via Investor Brand Network

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial

Today 10:05 EDT

Via Investor Brand Network

AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease

Today 9:00 EDT

Via NewMediaWire

Kaplan Fox Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Act Before the Lead Plaintiff Deadline on November 3, 2026

Today 8:45 EDT

Via NewMediaWire

3 Stocks BEAT, MOBX, PRSO Now: FDA Breakthrough, Rare Earths and Military Drones Drive Catalysts

Today 7:30 EDT

Via AB Newswire

Virility Medical Launches in2 Smart Wearable Device in the United States, Bringing New FDA-Cleared Healthcare Technology to US Consumers

October 05, 2026

Via GlobePRwire

Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026

October 05, 2026

Via NewMediaWire

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Receives FDA Breakthrough Device Designation for At-Home Heart Attack Assessment

October 05, 2026

Via Investor Brand Network

BBNX Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Beta Bionics, Inc.

October 05, 2026

Via Newsfile

UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.

October 05, 2026

Via Newsfile

Kaplan Fox is Investigating Possible Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)

October 05, 2026

Via NewMediaWire

Kaplan Fox Alerts Investors: Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is Under Investigation for Potential Securities Law Violations

October 05, 2026

Via NewMediaWire

Understanding How ‘Biosimilar’ Drugs Can Expand Access and Affordability

October 05, 2026

Via StatePoint Media

Invivyd’s VYD2311 Phase III Study Meets Safety Goals, Eyes FDA Accelerated Approval ↗

October 04, 2026

Via MarketBeat

PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data ↗

October 04, 2026

Via MarketBeat

Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years? ↗

October 04, 2026

Via The Motley Fool

Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing ↗

October 04, 2026

Via MarketBeat

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think. ↗

October 03, 2026

Via The Motley Fool

Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment ↗

October 03, 2026

Via MarketBeat

Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea — General Debate under Item 3, 63rd session of the Human Rights Council

October 03, 2026

Via 24-7 Press Release

Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) With Significant Losses to a Securities Class Action Deadline on November 3, 2026

October 02, 2026

Via NewMediaWire

NetworkNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Positions SSi Mantra for Next Phase of Expansion

October 02, 2026

Via Investor Brand Network

Kaplan Fox Class Action Reminder: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Lead Plaintiff Deadline is November 2, 2026

October 02, 2026

Via NewMediaWire

Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision ↗

October 02, 2026

Via MarketBeat

Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup ↗

October 02, 2026

Via MarketBeat

Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors Who Suffered Losses to a Securities Class Action - Deadline is November 3, 2026

October 01, 2026

Via NewMediaWire

Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to Contact the Firm Regarding Potential Securities Law Violations

October 01, 2026

Via NewMediaWire

Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) and Its Officers for Potential Securities Law Violations

October 01, 2026

Via NewMediaWire

Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026

October 01, 2026

Via NewMediaWire

OS Therapies Appoints Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer

October 01, 2026

Via Newsfile

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.